Recombinant C1 inhibitor: Began Phase I trial

Pharming Group N.V. (EASD:PHAR; AEX:PHAR), Leiden, the Netherlands Baxter International Inc. (BAX), Deerfield, Ill. Product: Recombinant C1 inhibitor Business: Cardiovascular Target: C1 Description:...